NIH: A Type of 'Step Therapy' Is an Effective Strategy for Diabetic Eye Disease
July 15, 2022
July 15, 2022
WASHINGTON, July 15 (TNSjou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on July 14, 2022:
Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced dr . . .
Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced dr . . .